/

Empresas

Sp

No verificado

SpliceBio

Sobre qué escribimos

BiologíaFarmacéuticaMedicina - VariosSaludSanidad

5 Comunicados de prensa

Ver todos los comunicados de prensa

08/01/2026

Biotecnología

Higiene alimentaria

Salud

Sanidad

Farmacéutica

Óptica

Oncología

Ciencia

Medicina - Varios

Industria

SpliceBio Initiates Dose-Expansion Portion of Phase 1/2 ASTRA Clinical Trial for SB-007, a Dual-AAV Gene Therapy for Stargardt Disease

Fuente

Editor

1.00

0

06/01/2026

SpliceBio Appoints Don Munoz as Chief Financial Officer

Fuente

Editor

1.00

0

11/06/2025

Salud

Fitness

Economía

Medicina - Varios

Medio Ambiente/Ecología

Agricultura

SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines

Fuente

Editor

1.00

0

13/03/2025

Farmacéutica

Sanidad

Biología

SpliceBio Announces First Patient Dosed in Phase 1/2 ASTRA Study of SB-007, a Dual-AAV Gene Therapy for Stargardt Disease

Fuente

Editor

1.00

0

12/12/2024

Farmacéutica

Sanidad

Biología

SpliceBio Announces U.S. FDA IND Clearance of SB-007 to Commence Phase 1/2 Clinical Study in Patients with Stargardt Disease

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0